Mixed adenoneuroendocrine carcinoma of the non-ampullary duodenum with mismatch repair deficiency: a rare case report
-
Published:2022-05-20
Issue:3
Volume:55
Page:258-266
-
ISSN:1860-1480
-
Container-title:Medical Molecular Morphology
-
language:en
-
Short-container-title:Med Mol Morphol
Author:
Nozawa Yumi, Ishida KazuyukiORCID, Maiko Niki, Takada-Owada Atsuko, Onozaki Masato, Takaoka Mina, Matsuyama Kinichi, Sakuraoka Yuhki, Nakazato Yoshimasa, Kubota Keiichi
Abstract
AbstractA non-ampullary duodenal mixed adenoneuroendocrine carcinoma (MANEC), consisting of a conventional adenocarcinoma and a neuroendocrine carcinoma (NEC), is exceedingly rare. Moreover, mismatch repair (MMR) deficient tumors have recently attracted attention. The patient, a 75-year-old woman with epigastric pain and nausea, was found to have a type 2 tumor of the duodenum, which was diagnosed on biopsy as a poorly differentiated carcinoma. A pancreaticoduodenectomy specimen showed a well-defined 50 × 48 mm tumor in the duodenal bulb, which was morphologically composed of glandular, sheet-like, and pleomorphic components. The glandular component was a tubular adenocarcinoma, showing a MUC5AC-positive gastric type. The sheet-like component consisted of homogenous tumor cells, with chromogranin A and synaptophysin diffusely positive, and a Ki-67 index of 72.8%. The pleomorphic component was diverse and prominent atypical tumor cells proliferated, focally positive for chromogranin A, diffusely positive for synaptophysin, and the Ki-67 index was 67.1%. The sheet-like and pleomorphic components were considered NEC, showing aberrant expression of p53, retinoblastoma, and p16. Notably, all three components were deficient in MLH1 and PMS2. We diagnosed a non-ampullary duodenal MANEC with MMR deficiency. This tumor has a unique morphology and immunohistochemical profile, and is valuable for clarifying the tumorigenesis mechanism of a non-ampullary duodenal MANEC.
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,General Medicine,Pathology and Forensic Medicine
Reference31 articles.
1. Klimstra DS, Klöppel G, La Rosa S, Rindi G (2019) Classification of neuroendocrine neoplasms of the digestive systems. In: WHO Classification of Tumours Editorial Board (eds) Digestive system tumours. International Agency for Research on Cancer, Lyon, pp16–19 2. Milione M, Maisonneuve P, Pellegrinelli A, Grillo F, Albarello L, Spaggiari P, Vanoli A, Tagliabue G, Pisa E, Messerini L, Centonze G, Inzani F, Scarpa A, Papotti M, Volante M, Sessa F, Fazio N, Pruneri G, Rindi G, Solcia E, La Rosa S, Capella C (2018) Ki67 proliferative index of the neuroendocrine component drives MANEC prognosis. Endocr Relat Cancer 25:583–593 3. Milione M, Parente P, Grillo F, Zamboni G, Mastracci L, Capella C, Fassan M, Vanoli A (2021) Neuroendocrine neoplasms of the duodenum, ampullary region, jejunum and ileum. Pathologica 113:12–18 4. Konukiewitz B, Kasajima A, Schmitt M, Schwamborn K, Groll T, Schicktanz F, Delbridge C, Schütze LM, Wilhelm D, Lang C, Lange S, Foersch S, Jank P, Steiger K, Werder AV, Denkert C, Weichert W, Klöppel G, Jesinghaus M (2021) Neuroendocrine differentiation in conventional colorectal adenocarcinomas: incidental finding or prognostic biomarker? Cancers (Basel) 13:5111 5. Jesinghaus M, Schmitt M, Lang C, Reiser M, Scheiter A, Konukiewitz B, Steiger K, Silva M, Tschurtschenthaler M, Lange S, Foersch S, Becker KF, Saur D, Friess H, Halfter K, Engel J, Boxberg M, Pfarr N, Wilhelm D, Weichert W (2021) Morphology matters: a critical reappraisal of the clinical relevance of morphologic criteria from the 2019 WHO classification in a large colorectal cancer cohort comprising 1004 cases. Am J Surg Pathol 45:969–978
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|